EWA
TWST icon

EP Wealth Advisors’s Twist Bioscience TWST Stock Holding History

EP Wealth Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$492K Sell
4,786
-188
-4% -$12.2K ﹤0.01% 1039
2026
Q1 		$236K Buy
+4,974
New +$223K ﹤0.01% 1309

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

EP Wealth Advisors's TWST Position: Q2 2026 in Review

EP Wealth Advisors reduced its Twist Bioscience (TWST) stake by 3.8% in Q2 2026, selling an estimated $12.2K and leaving 4,786 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

EP Wealth Advisors first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • EP Wealth Advisors held 4,786 shares of Twist Bioscience worth $492K as of Q2 2026.
  • EP Wealth Advisors sold 188 Twist Bioscience shares in Q2 2026, an estimated $12.2K.
  • Twist Bioscience made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #1039 holding.
  • EP Wealth Advisors first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.